Professor Sir Munir Pirmohamed MB ChB (Hons), MRCP, PhD, FRCP, FRCP(E), FBPharmacolS

Professor (Clin,Hcc) Molecular and Clinical Pharmacology

    Biography

    Personal Distinctions

    • NIHR Senior Investigator (Competitive Fellowship, NIHR 2008)
    • Designer Medicines (Invitation to Speak, ASE 2008)
    • Cytochrome P450 testing: A case study (Invitation to Speak, Academy of Medical Sciences 2007)
    • Safety Monitoring (Invitation to Speak, MHRA 2007)
    • Adverse drug reactions: which one’s can we predict? The clinical perspective (Invitation to Speak, Gordon Research Conferences 2007)
    • Will pharmacogenetics ever have a role in pharmacovigilance? (Invitation to Speak, EACPT 2007)
    • Pharmacogenetics of adverse drug reactions and role in pharmacovigilance (Invitation to Speak, University of Canberrra 2007)
    • Pharmacogenetics: current situation, challenges and opportunities (Invitation to Speak, University of Bendigo, Australia 2007)
    • Pharmacogenomics and the cardiovascular system: challenges and opportunities (Invitation to Speak, Baker Heart Research Institute, Melbourne, Australia 2007)
    • Pharmacogenetics of adverse drug reactions (Invitation to Speak, Royal Society of Medicine 2007)
    • Yellow cards – moving forwards (Invitation to Speak, MHRA 2007)
    • Pharmacogenetics in Gastroenterology (Invitation to Speak, University of Nottingham 2007)
    • Pharmacogenetics: a clinical perspective (Invitation to Speak, Epidauros 2007)
    • Hapten-independent T-cell drug reactions: evidence and implications (Invitation to Speak, AAAAI 2007)
    • Pharmacogenetics: hype or hope? (Invitation to Speak, European College of Neuro-Psychopharmacology 2007)
    • Pharmacogenetics in drug hypersensitivity (Invitation to Speak, Swiss Society of Allergy and Immunology, and the Swiss Society of Dermatology and Venereology 2007)
    • Pharmacogenetics of adverse drug reactions (Invitation to Speak, Conference Organisers 2007)
    • BPS Australasian Visitor (British Pharmacological Society 2007)
    • Pharmacogenetics: present situation and perspectives on clinical application (Invitation to Speak, ESF 2007)
    • Idiosyncratic adverse drug reactions: from molecule to man (Invitation to Speak, St Vincent's Hospital, Sydney, Australia 2007)
    • Adverse drug reactions (Invitation to Speak, Therapeutics and Goods Administration. Canberra, Australia 2007)
    • Pharmacogenetic prediction of adverse drug reactions (Invitation to Speak, ASCEPT 2007)
    • Adverse drug reactions: from patients to genes (Invitation to Speak, ASCEPT 2007)
    • Pharmacogenomics and pharmacovigilance (Invitation to Speak, Indo-French Collaboration 2007)
    • Personalising risk for the patient over the next 20 year. (Invitation to Speak, BrAPP, FPS, RSM 2007)
    • Pharmacogenetics: current status, future challenges (Invitation to Speak, ESPR 2007)
    • The skin, drugs and T-cells: a significant, but sometimes uncomfortable, threesome (Invitation to Speak, Toronto Western Hospital 2007)
    • Pharmacogenetics of drug hypersensitivity (Invitation to Speak, ISOP 2007)
    • Anti-epileptic drugs: past, present and future (Invitation to Speak, ER-UK 2007)
    • Genetic prediction of adverse drug reactions (Invitation to Speak, ISOP 2006)
    • Recent initiatives in pharmacogenetics in the UK (Invitation to Speak, NIH Pharmacogenetics Research Network 2006)
    • Pharmacogenetics: theoretical background and practical problems (Invitation to Speak, IUPHAR 2006)
    • Will pharmacogenetics ever have a role in pharmacovigilanc? (Invitation to Speak, Conference Organisers 2006)
    • Genetic basis of adverse drug reactions (Invitation to Speak, DG Research 2006)
    • The future of pharmacogenetics and its impact on healthcare systems (Invitation to Speak, MHRA 2006)
    • Pharmacogenetics in practice: the challenge of translation (Invitation to Speak, Generation Scotland 2006)
    • Adverse drug reactions: incidence and role of pharmacists (Invitation to Speak, UK Medicine Information Pharmacists 2006)
    • Pharmacogenetics and adverse drug reactions (Invitation to Speak, RPSGB 2006)
    • Personalised pills. From Pythagoras to the present (Invitation to Speak, British Pharmacological Society 2006)
    • Why are some patients harmed by a medicine while others are not? (Invitation to Speak, British Society for Ecological Medicine 2006)
    • Individual basis of susceptibility to adverse drug reactions (Invitation to Speak, ISSX 2006)
    • Drug safety: scale of the problems and developing solutions (Invitation to Speak, Southport District General Hospital 2006)
    • Pharmacogenomics of herbal medicines (Invitation to Speak, Conference Organisers 2006)
    • Recent advances in pharmaco- and immunogenetics (Invitation to Speak, Conference Organisers 2006)
    • This is the drug for you, Madam (Invitation to Speak, Epilepsy Research Foundation 2006)
    • Optimal genotyping strategies in pharmacogenomics (Invitation to Speak, Genomes to Systems Conference. Manchester 2006)
    • Mechanisms of drug-induced hepatotoxicity (Invitation to Speak, British Co-Infection Association 2006)
    • Pharmacogenetics in clinical practice: the problem of translation (Invitation to Speak, Dutch Royal Pharmaceutical Society 2006)
    • Pharmacogenetics: current status and future potential (Invitation to Speak, MerseyBio 2005)
    • Pharmacogenetics: Study Designs, Potential Problems and Possible Solutions (Invitation to Speak, Drug Safety Research Unit 2005)
    • Pharmacogenetics and Clinical Practice: Challenges and Prospects (Invitation to Speak, GlaxoSmithKline Pharmaceuticals 2005)
    • Cardiovascular pharmacogenetics (Invitation to Speak, London Hypertension Society 2005)
    • Principles of pharmacogenetics, problems and possible solutions (Invitation to Speak, British Society of Gastroenterology 2005)
    • Pharmacovigilance in the future (Invitation to Speak, EMEA 2005)
    • Fellowship (British Pharmacological Society 2005)
    • Drug safety: a continuing public health problem (Invitation to Speak, Royal College of Physiciana 2005)
    • Epilepsy pharmacogenetics (Invitation to Speak, Banbury Centre, Cold Spring Harbor Laboratory 2005)
    • Drug Safety: Defining the Problems and Developing Solutions (Invitation to Speak, University of Toronto 2005)
    • Drug-induced liver injury: working towards better diagnostic and preventive strategies (Invitation to Speak, Gordon Research Conferences 2005)
    • Genetic aspects of drug-induced hypersensitivity reactions (Invitation to Speak, Gordon Research Conferences 2005)
    • New Insights into the Pathogenesis of Allergic Drug Reactions (Invitation to Speak, American Academy of Allergy, Asthma and Immunology 2005)
    • Immune Pathogenesis of Drug-Induced Liver Disease (Invitation to Speak, Swiss Society for Allergology and Immunology 2005)
    • Pharmacogenetics of HIV therapy (Invitation to Speak, London IDEAS Genetics Knowledge Park 2005)
    • Pharmacogenetics (Invitation to Speak, Cambridge Genetics Knowledge Park 2005)
    • What are personalised medicines and what will they mean to the dynamics of healthcare? (Invitation to Speak, Tech-Link Ireland 2005)
    • Pharmacogenetics of adverse drug reactions (Invitation to Speak, PK-UK 2005)
    • Immune-mediated drug hypersensitivity: an overview (Invitation to Speak, British Society of Allergy and Clinical Immunology 2005)
    • Pharmacogenetics of antiepileptic drugs (Invitation to Speak, Royal Liverpool Childrens Hospital 2005)
    • Drug interactions: new mechanisms, new issues (Invitation to Speak, Royal College of Physicians of Edinburgh 2005)
    • Pharmacogenomics: current status (Invitation to Speak, University of Edinburgh 2005)
    • Pharmacogenetics and antiviral drugs (Invitation to Speak, IFCC-FESCC 2005)

    Untitled Document